WCLC 2025 - Posters & ePosters-P2.06.59 Multi-Level Screening of MET Aberrations in Treatment-Resistant Non-Small Cell Lung Cancer: A Report From LC-SCRUM-TRY

P2.06.59 Multi-Level Screening of MET Aberrations in Treatment-Resistant Non-Small Cell Lung Cancer: A Report From LC-SCRUM-TRY

Asset Subtitle

Tetsuro Taki

Meta Tag

Speaker Tetsuro Taki

Topic Pathology and Biomarkers